1. Home
  2. |Insights
  3. |ACI's 15th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions

ACI's 15th Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions

Event | 07.20.11 - 07.21.11, 12:00 AM UTC - 12:00 AM UTC

Address

Sheraton Fisherman's Wharf

Life science companies’ future successes hinge upon successful partnerships- gain the advanced strategies your company needs to maximize profit revenue by forging mutually beneficial collaborative agreements.

The flurry of big-dollar deals and the upswing in mergers and acquisitions in 2011 points to a clear trend: successful collaborative agreements are integral to a company’s ability to bring products to the market and to develop the next generation of therapeutic blockbusters in light of the impending patent cliff. AtACI’s Fifteenth Advanced Forum on Structuring, Negotiating, and Managing Life Sciences Collaborative Agreements and Acquisitions, learn proven effective techniques to structure alliances and negotiate the best terms to meet your company’s critical needs.

Jeff Selman is one of the speakers on the topic, "Utilizing Applicable Valuation Models to Set Realistic Expectations for a Deal."

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.